Wound-Healing Effects of Common Antineoplastic Agents and Perioperative Considerations for the Orthopaedic Surgeon.

J Am Acad Orthop Surg · Jul 15 2024 · Review

Okay E, Connolly JJ, Gonzalez MR, Lozano-Calderon SA

From the Division of Orthopaedic Oncology, Department of Orthopaedic Surgery, Massachusetts General Hospital, MA

Orthopaedic Oncology

SUMMARY — THE REDUCTIONReview outlines how various antineoplastic agents affect wound healing and offers perioperative cessation guidance to reduce wound complications in oncologic orthopaedic patients.
Abstract, as published

In oncologic patients, optimal postoperative wound healing is crucial for the maintenance of systemic therapies and improved survival. Although several risk factors for postoperative wound complications have been identified, the clinical effect of new antineoplastic agents on wound healing remains uncertain. The available literature on the effect of antineoplastic agents in wound healing is complex to analyze because of other confounding risk factors such as radiation therapy and certain patient-specific variables. Available perioperative drug recommendations are based on database opinion and case reports from adverse event alerts. This review highlights the characteristics of old and new antineoplastic agents commonly used in the treatment of sarcoma, carcinoma, and other cancers and their potential effects on the wound-healing process. It also aims to provide perioperative treatment cessation recommendations to guide orthopaedic surgeons and prevent drug-related wound complications to the fullest extent possible.

Featured in the 2026-09-12 issue.

← Endoprosthetic Use in Pediatric and Adolescent Lower Limb Sar…Association between serum preptin levels and bone metastasis … →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.